Marshall Fordyce, PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 34,200 shares at $46.91 ($1.6M) on 2024-12-11, disclosed to the SEC on 2024-12-13.
Scheduled sale ($1.6M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.91 | 14,925 | $700K | 43.6% |
| 2 | $46.91 | 14,925 | $700K | 43.6% |
| 3 | $46.94 | 1,775 | $83K | 5.2% |
| 4 | $46.94 | 1,775 | $83K | 5.2% |
| 5 | $47.55 | 700 | $33K | 2.1% |
| 6 | $47.65 | 100 |
| $5K |
| 0.3% |
| Total | $46.93 avg | 34,200 | $1.6M | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |